Evaluation of safety and efficacy as an adjuvant for the chitosan-based vaccine delivery vehicle ViscoGel in a single-blind randomised Phase I/IIa clinical trial

Autor: Neimert-Andersson, Theresa, Binnmyr, Jonas, Enoksson, Mattias, Langebäck, Joakim, Zettergren, Louise, Hällgren, Anne-Charlotte, Franzén, Henry, Lind Enoksson, Sara, Lafolie, Pierre, Lindberg, Alf, Al-Tawil, Nabil, Andersson, Mats, Singer, Peter, Grönlund, Hans, Gafvelin, Guro
Zdroj: In Vaccine 14 October 2014 32(45):5967-5974
Databáze: ScienceDirect